As of January 2023 Roche has a market cap of $255.96 Billion. This makes Roche the world's 34th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $255.96 B | -1.38% |
2022 | $259.55 B | -27.83% |
2021 | $359.63 B | 20.2% |
2020 | $299.20 B | 8.27% |
2019 | $276.35 B | 31.2% |
2018 | $210.64 B | -1.97% |
2017 | $214.86 B | 9.77% |
2016 | $195.74 B | -17.9% |
2015 | $238.41 B | 2.92% |
2014 | $231.65 B | -2.73% |
2013 | $238.15 B | -24.51% |
2012 | $315.46 B | 114.14% |
2011 | $147.31 B | 15.59% |
2010 | $127.44 B | -14.38% |
2009 | $148.85 B | 9.99% |
2008 | $135.33 B | -10.67% |
2007 | $151.50 B | -1.96% |
2006 | $154.53 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $439.83 B | 71.84% | ๐บ๐ธ USA |
![]() Novartis NVS | $193.01 B | -24.59% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $245.80 B | -3.97% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $191.70 B | -25.10% | ๐บ๐ธ USA |
![]() Amgen AMGN | $135.34 B | -47.12% | ๐บ๐ธ USA |
![]() Sanofi SNY | $122.89 B | -51.99% | ๐ซ๐ท France |
![]() Becton Dickinson BDX | $71.58 B | -72.03% | ๐บ๐ธ USA |
![]() Merck MRK | $267.18 B | 4.38% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $72.26 B | -71.77% | ๐ฌ๐ง UK |